Literature DB >> 8980108

Structural classification of CDR-H3 in antibodies.

H Shirai1, A Kidera, H Nakamura.   

Abstract

Large varieties in the lengths and the amino acid sequences of the third complementarity determining region of the antibody heavy chain (CDR-H3) have made it difficult to establish a relationship between the sequences and the tertiary structures, in contrast to the other CDRs, which are classified by their canonical structures. A total of 55 CDR-H3 segments from well determined crystal structures were analyzed, and we have derived several remarkable rules, which could partly govern the CDR-H3 conformation dependence on the sequence. Since the rules are physically reasonable, they are expected to be applicable to structural modeling and design of antibodies.

Mesh:

Substances:

Year:  1996        PMID: 8980108     DOI: 10.1016/s0014-5793(96)01252-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  55 in total

1.  Cyclic peptide formation catalyzed by an antibody ligase.

Authors:  D B Smithrud; P A Benkovic; S J Benkovic; V Roberts; J Liu; I Neagu; S Iwama; B W Phillips; A B Smith; R Hirschmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.

Authors:  Yuko Tsuchiya; Kenji Mizuguchi
Journal:  Protein Sci       Date:  2016-01-20       Impact factor: 6.725

3.  A new clustering of antibody CDR loop conformations.

Authors:  Benjamin North; Andreas Lehmann; Roland L Dunbrack
Journal:  J Mol Biol       Date:  2010-10-28       Impact factor: 5.469

4.  Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization.

Authors:  Christian H Bell; Ralph Pantophlet; André Schiefner; Lisa A Cavacini; Robyn L Stanfield; Dennis R Burton; Ian A Wilson
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

5.  Analysis of cross-reactive and specific anti-carbohydrate antibodies against lipopolysaccharide from Chlamydophila psittaci.

Authors:  Sandra Gerstenbruch; Cory L Brooks; Paul Kosma; Lore Brade; C Roger Mackenzie; Stephen V Evans; Helmut Brade; Sven Müller-Loennies
Journal:  Glycobiology       Date:  2009-12-18       Impact factor: 4.313

6.  Antibody modeling using the prediction of immunoglobulin structure (PIGS) web server [corrected].

Authors:  Paolo Marcatili; Pier Paolo Olimpieri; Anna Chailyan; Anna Tramontano
Journal:  Nat Protoc       Date:  2014-11-06       Impact factor: 13.491

7.  Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.

Authors:  Karen A Kirby; Yee Tsuey Ong; Atsuko Hachiya; Thomas G Laughlin; Leslie A Chiang; Yun Pan; Jennifer L Moran; Bruno Marchand; Kamalendra Singh; Fabio Gallazzi; Thomas P Quinn; Kazuhisa Yoshimura; Toshio Murakami; Shuzo Matsushita; Stefan G Sarafianos
Journal:  FASEB J       Date:  2014-10-28       Impact factor: 5.191

8.  Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.

Authors:  Robyn L Stanfield; Miroslaw K Gorny; Susan Zolla-Pazner; Ian A Wilson
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.

Authors:  Elena Gabrielli; Eva Pericolini; Elio Cenci; Federica Ortelli; Walter Magliani; Tecla Ciociola; Francesco Bistoni; Stefania Conti; Anna Vecchiarelli; Luciano Polonelli
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

10.  SnugDock: paratope structural optimization during antibody-antigen docking compensates for errors in antibody homology models.

Authors:  Aroop Sircar; Jeffrey J Gray
Journal:  PLoS Comput Biol       Date:  2010-01-22       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.